202197-78-2

Usage

Uses

Used in Pharmaceutical Industry:
4-CHLORO-7-IODOQUINAZOLINE is used as a building block for the synthesis of various organic compounds, which can be utilized in the development of new pharmaceuticals. Its unique structure and the presence of halogen substituents may contribute to its potential as a drug candidate, offering novel therapeutic options.
Used in Agrochemical Industry:
In the agrochemical field, 4-CHLORO-7-IODOQUINAZOLINE is employed as a precursor to other biologically active molecules. Its chemical properties and structural features make it a valuable component in the creation of new agrochemicals, potentially leading to advancements in pest control and crop protection.
Further research and studies are necessary to fully understand the scope of 4-CHLORO-7-IODOQUINAZOLINE's applications and to harness its potential in both the pharmaceutical and agrochemical industries.

Upstream product

• 20776-54-9 2-amino-4-iodobenzoic acid 
• 202197-77-1 4-hydroxy-7-iodoquinazoline 
• 41252-97-5 4-iodo-2-nitrotoluene 
• 116529-62-5 4-iodo-2-nitro benzoic acid 
• 90004-09-4 7?aminoquinazolin?4(3H)?one 
• 202197-77-1 7-iodo-1H-quinazolin-4-one 

Downstream Products

• 202197-79-3 (1-benzyl-1H-indazol-5-yl)-(7-iodoquinazolin-4-yl)-amine hydrochloride 

Relevant academic research and scientific papers

Novel quinazoline-containing compound, and intermediate and application thereof

The present invention discloses a quinazoline-containing compound having the formula (IA), (IB) or (IC), or a pharmaceutically acceptable salt or a prodrug molecule thereof. The compound is suitable for use as an Aurora kinase inhibitor and is thus suitable for the treatment of Aurora-mediated diseases characterized by excessive or abnormal cell proliferation, for example, cancer.

Bicyclic heteroaromatic compounds as protein tyrosine kinase inhibitors

A pharmaceutical formulation comprising the compound of formula

CANCER TREATMENT METHOD

A method of treating cancer is described including administration of a 4-quinazolineamine and at least one other anti-neoplastic agent as well as a pharmaceutical combination including the 4-quinazolineamines.

Anilinoquinazolines as protein tyrosine kinase inhibitors

Heteroaromatic compounds are described, methods for their preparation, pharmaceutical compositions containing them, methods of use, and their use in medicines. In particular, the invention relates to quinazoline and pyridopyrimidine derivatives which exhibit protein tyrosine kinase inhibition.

Anilinoquinazaolines as protein tyrosine kianse inhibitors

Heteroaromatic compounds are described, methods for their preparation, pharmaceutical compositions containing them, methods of use, and their use in medicines. In particular, the invention relates to quinazoline and pyridopyrimidine derivatives which exhibit protein tyrosine kinase inhibition.

Cancer treatment method

A method of treating cancer is described including administration of a 4-quinazolineamine and at least one other anti-neoplastic agent as well as a pharmaceutical combination including the 4-quinazolineamines.